Impact of transplanted CD 34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation.

被引：0
|
作者：
Sohn, SK [1 ]
Kim, DH [1 ]
Kim, JG [1 ]
Suh, JS [1 ]
Lee, KB [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5387
引用
收藏
页码：453B / 453B
页数：1
相关论文
共 50 条
  • [1] Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    S K Sohn
    J G Kim
    D H Kim
    N Y Lee
    J S Suh
    K B Lee
    Bone Marrow Transplantation, 2003, 31 : 967 - 972
  • [2] Impact of transplanted CD34+cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    Sohn, SK
    Kim, JG
    Kim, DH
    Lee, NY
    Suh, JS
    Lee, KB
    BONE MARROW TRANSPLANTATION, 2003, 31 (11) : 967 - 972
  • [3] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71
  • [4] Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
    Yamamoto, Chihiro
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Igarashi, Aiko
    Okumura, Hirokazu
    Uchida, Naoyuki
    Hidaka, Michihiro
    Nakamae, Hirohisa
    Matsuoka, Ken-Ichi
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 708 - 716
  • [5] Impact of CD34+ Stem Cell Dose on Engraftment Period in Allogeneic Peripheral Blood Stem Cell Transplanted Patients
    Suria, A. A.
    Diyana, Hazlina B.
    Zakari, Zed A. H.
    Nurasyikin, Y.
    Yousuf, R.
    Azma, R. Z.
    MEDICINE AND HEALTH, 2021, 16 (01): : 39 - 49
  • [6] Severe infections after allogeneic peripheral blood stem cell transplantation:: A matched-pair comparison of unmanipulated and CD34+cell-selected transplantation.
    Martino, R
    Rovira, M
    Carreras, E
    Solano, C
    Sierra, J
    De la Rubia, J
    Caballero, MD
    de Oteyza, JP
    Zuazu, J
    Moraleda, JM
    Ojeda, E
    Ferra, C
    Serrano, D
    De la Camara, R
    Urbano-Isìzua, A
    Brunet, S
    BLOOD, 2000, 96 (11) : 785A - 785A
  • [7] Impact of CD34+Graft Cell Dose on Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation
    Chaudhary, Sibgha Gull
    Shahzad, Moazzam
    Anwar, Iqra
    Amin, Muhammad Kashif
    Irfan, Sohaib
    Mcguirk, Matthew
    Dejarnette, Shaun
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Abhyankar, Sunil
    Mcguirk, Joseph P.
    Mushtaq, Muhammad Umair
    BLOOD, 2024, 144 : 7305 - 7306
  • [8] CD34 cell dose influences hematological recovery after peripheral blood stem cell transplantation.
    Ilhan, O
    Beksac, M
    Arslan, O
    Akan, H
    Koc, H
    Dilek, I
    Arat, M
    Ozcan, M
    Gurman, G
    Konuk, N
    Uysal, A
    BLOOD, 1996, 88 (10) : 3751 - 3751
  • [9] The CD34+cell dose, even in an "acceptable" range, affects outcome of allogeneic blood stem cell transplantation.
    Singhal, S
    Gordon, L
    Meagher, R
    Evens, A
    Tallman, M
    Williams, S
    Winter, J
    Grinblatt, D
    Kaminer, L
    Mehta, J
    BLOOD, 2004, 104 (11) : 326A - 327A
  • [10] Optimizing the CD34+Cell Dose for Allogeneic Transplantation.
    Mehta, J.
    Evens, Andrew M.
    Altman, J.
    Frankfurt, O.
    Tallman, Martin
    Gordon, L.
    Williams, S.
    Winter, J.
    Krishnamurthy, J.
    Duffey, S.
    Singh, V.
    Meagher, R.
    Singhal, S.
    BLOOD, 2008, 112 (11) : 408 - 409
12345